Literature DB >> 25541165

Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis.

Stephen D Lawn1, Mark P Nicol2, Elizabeth L Corbett3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25541165     DOI： 10.1016/S1473-3099(14)71049-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  8 in total

1.  Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.

Authors:  T Agizew; R Boyd; A F Auld; L Payton; S L Pals; P Lekone; V Chihota; A Finlay
Journal:  Int J Tuberc Lung Dis       Date:  2019-01-01       Impact factor: 2.373

2.  The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.

Authors:  Swe Swe Thit; Ne Myo Aung; Zaw Win Htet; Mark A Boyd; Htin Aung Saw; Nicholas M Anstey; Tint Tint Kyi; David A Cooper; Mar Mar Kyi; Josh Hanson
Journal:  BMC Med       Date:  2017-08-04       Impact factor: 8.775

3.  Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation.

Authors:  Anna Vassall; Mariana Siapka; Nicola Foster; Lucy Cunnama; Lebogang Ramma; Katherine Fielding; Kerrigan McCarthy; Gavin Churchyard; Alison Grant; Edina Sinanovic
Journal:  Lancet Glob Health       Date:  2017-07       Impact factor: 26.763

4.  Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.

Authors:  Tefera Agizew; Violet Chihota; Sambayawo Nyirenda; Zegabriel Tedla; Andrew F Auld; Unami Mathebula; Anikie Mathoma; Rosanna Boyd; Anand Date; Sherri L Pals; Phenyo Lekone; Alyssa Finlay
Journal:  BMC Infect Dis       Date:  2019-12-16       Impact factor: 3.090

5.  Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial.

Authors:  Ankur Gupta-Wright; Katherine L Fielding; Joep J van Oosterhout; Douglas K Wilson; Elizabeth L Corbett; Clare Flach; Krishna P Reddy; Rochelle P Walensky; Jurgens A Peters; Melanie Alufandika-Moyo; Stephen D Lawn
Journal:  BMC Infect Dis       Date:  2016-09-22       Impact factor: 3.090

6.  Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.

Authors:  Ankur Gupta-Wright; Elizabeth L Corbett; Joep J van Oosterhout; Douglas Wilson; Daniel Grint; Melanie Alufandika-Moyo; Jurgens A Peters; Lingstone Chiume; Clare Flach; Stephen D Lawn; Katherine Fielding
Journal:  Lancet       Date:  2018-07-20       Impact factor: 79.321

7.  Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.

Authors:  Gian Luca Di Tanna; Ali Raza Khaki; Grant Theron; Kerrigan McCarthy; Helen Cox; Lucy Mupfumi; Anete Trajman; Lynn Sodai Zijenah; Peter Mason; Tsitsi Bandason; Betina Durovni; Wilbert Bara; Michael Hoelscher; Petra Clowes; Chacha Mangu; Duncan Chanda; Alexander Pym; Peter Mwaba; Frank Cobelens; Mark P Nicol; Keertan Dheda; Gavin Churchyard; Katherine Fielding; John Z Metcalfe
Journal:  Lancet Glob Health       Date:  2019-02       Impact factor: 26.763

8.  Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial.

Authors:  Andrew F Auld; Tefera Agizew; Anikie Mathoma; Rosanna Boyd; Anand Date; Sherri L Pals; Christopher Serumola; Unami Mathebula; Heather Alexander; Tedd V Ellerbrock; Goabaone Rankgoane-Pono; Pontsho Pono; James C Shepherd; Katherine Fielding; Alison D Grant; Alyssa Finlay
Journal:  BMC Med       Date:  2020-02-11       Impact factor: 8.775
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.